Having trouble accessing articles? Reset your cache.

Sutent sunitinib: Phase III discontinued

Pfizer discontinued the double-blind, international Phase III SUN 1120 trial after an interim analysis by the study's

Read the full 178 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE